Response to an Outbreak: Ebola Virus Monoclonal Antibody (mAb114) Rapid Clinical Development

Source: National Institutes of Health (NIH). Published: 3/13/2019. This one-hour lecture describes the discovery and development of a human monoclonal antibody (mAb114) targeting Ebola, discusses the safety and pharmacokinetic data resulting from Phase 1 and follow-on trials of mAb114, and discusses progress to date utilizing monoclonal antibody treatment strategies and remaining challenges. It also details related activities at the National Institute of Allergy and Infectious Diseases. (Video or Multimedia)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news